Stop Gambling in the Stock Market. Be an intelligent and confident investor.
See what the professionals see with financial analytics, charts and valuation models.
Fundamental Analysis and Stock Valuation Simplified. Learn more.

Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance Trend  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  | Income Statement  |  Cash Flow  |  Quarterly
INR in Million except EPS. Fiscal year ends in March. Figures are consolidated and restated.

Upgrade Membership to see 10 year financial statements.

  
2015
2016
2017
2018
2019
Revenue
Revenue
31,14937,76441,06339,12849,463
Cost of revenue
Cost of revenue
-12,132-15,053-15,759-15,554-18,252
Gross Profit
Gross Profit
19,017
22,710
25,303
23,574
31,210
Sales, general & ad...
Sales, general and administrative
-7,365-8,573-10,843-10,957-12,492
Depreciation
Depreciation and amortization
-1,360-1,182-1,233-1,425-1,689
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
10,292
12,956
13,227
11,192
17,029
 
      
Interest expense
Interest expense
-19-23-23-13-35
Other income/exp...
Other income(expense)
4478487491,1341,556
Profit before tax
Profit before tax
10,721
13,781
13,953
12,313
18,551
Income tax & other ta...
Income tax and other taxes
2,2062,6623,3543,5435,023
Net income from c...
Net income from continuing operations
8,51511,11810,6008,77013,527
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00400
Share of associates
Share of associates
00000
Minority Interest
Minority Interest
00000
Net Income
Net income
8,515
11,118
10,604
8,770
13,527
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
8,51511,11810,6048,77013,527
Basic shares
Basic shares
265265265265265
Diluted Shares
Diluted Shares
265265265265265
EPS Basic
EPS Basic in Rupees
32.0841.8839.9533.0450.96
EPS Diluted
EPS Diluted in Rupees
32.08
41.88
39.95
33.04
50.96